Clinical Trial Update: Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial [Phase 1, Phase 2]

View source ↗

Summary

The document provides results from a phase 1/2 exploratory trial evaluating atorvastatin for cerebral cavernous malformations with symptomatic hemorrhage (AT CA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Cavernous Malformation

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of Chicago | Conditions: Cerebral Cavernous Malformation | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-08-22